{"transactions":[{"id":756857,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":42759,"kind":"person","name":"Lundgren Erik","position":1,"cik":"0002137540","reported_name":"Lundgren Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-06-01T21:57:14.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options disclosed on this Form 4 are time vested; twenty-five percent (25%) of the shares underlying the options awarded to the Reporting Person will vest on May 22, 2027, and the remaining seventy-five percent (75%) vesting on a monthly basis in thirty-six (36) equal installments, subject to the Reporting Person remaining an employee of Immunic, Inc. in good standing through the relevant vesting date. The Reporting Person became a director and a Section 16 insider on June 1, 2026."}],"balance_after":1000000,"derivative":{"exercise_price":13.05,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001193805-26-000731","document":"e665512_4-lundgren.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000731/e665512_4-lundgren.xml","form_type":"4"}}]}